Abiopharma

🔍 BRYANT DAVID J (Director)

Company: ACRES Commercial Realty Corp. (ACR)

Report Date: 2026-08-06

Detailed Transactions and Holdings:

• Acquired 2,123 shares of Common Stock (Direct)
  Date: 2026-08-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 47,198.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Acquired 2,054 shares of Common Stock (Direct)
  Date: 2026-08-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 49,252.00 | transaction_form_type: 4 | Footnotes: F2, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-06 | Code: H | nature_of_ownership: Spouse IRA | shares_owned_after: 83.00

Footnotes:

• F1: Pursuant to the Agreement and Plan of Merger, dated April 29, 2026, between ACRES Commercial Realty Corp. (the "Company") and ACRES Holdings Sub LLC, a subsidiary of the Company, on the one hand, and ACRES Capital Corp ("ACC") and ACRES Capital, LLC, a subsidiary of ACC and the external manager of the Company, on the other hand, (i) each outstanding share of common stock, $0.0001 par value per share, of ACC converted into the right to receive 2.61882 shares of common stock, $0.001 par value per share, of the Company.
• F2: The reporting person has been issued 2,054 shares of common stock under the Issuer's 2026 Omnibus Equity Incentive Plan.